Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L W Fleming

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
British Medical Journal (Clinical Research Ed.)|October 31, 1981
Vitamin A toxicity and hypercalcaemia in chronic renal failureW K Stewart, L W Fleming
Lancet (London, England)|October 16, 1971
Effects of magnesium on parathyroid hormone secretion during chronic haemodialysisW K Stewart, L W Fleming
Postgraduate Medical Journal|March 1, 1973
Features of a successful therapeutic fast of 382 days' durationW K Stewart, L W Fleming
Nephron|January 1, 1982
Plasma retinol and retinol binding protein concentrations in patients on maintenance haemodialysis with and without vitamin A supplementsW K Stewart, L W Fleming
Lancet (London, England)|December 10, 1983
Preventing CAPD peritonitisW K Stewart, L W Fleming
Nephron|January 1, 1973
The effect of dialysate magnesium on plasma and erythrocyte magnesium and potassium concentrations during maintenance haemodialysisW K Stewart, L W Fleming
Nephron|January 1, 1974
Plasma calcium and the optimum dialysate calcium concentration during maintenance haemodialysisL W Fleming, W K Stewart
British Medical Journal|November 24, 1973
Letter: Muscle cramps during maintenance haemodialysisW K Stewart, L W Fleming
The Journal of Hospital Infection|August 1, 1989
The potential hazard of using multiple-dose heparin and insulin vials in continuous ambulatory peritoneal dialysisG Phillips, L W Fleming, W K Stewart
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1992
Dextran antibodies, complement conversion and circulating immune complexes after intravenous iron dextran therapy in dialysed patientsL W Fleming, W K Stewart, D Parratt
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
British Medical Journal (Clinical Research Ed.)|October 31, 1981
Vitamin A toxicity and hypercalcaemia in chronic renal failureW K Stewart, L W Fleming
Lancet (London, England)|October 16, 1971
Effects of magnesium on parathyroid hormone secretion during chronic haemodialysisW K Stewart, L W Fleming
Postgraduate Medical Journal|March 1, 1973
Features of a successful therapeutic fast of 382 days' durationW K Stewart, L W Fleming
Nephron|January 1, 1982
Plasma retinol and retinol binding protein concentrations in patients on maintenance haemodialysis with and without vitamin A supplementsW K Stewart, L W Fleming
Lancet (London, England)|December 10, 1983
Preventing CAPD peritonitisW K Stewart, L W Fleming
Nephron|January 1, 1973
The effect of dialysate magnesium on plasma and erythrocyte magnesium and potassium concentrations during maintenance haemodialysisW K Stewart, L W Fleming
Nephron|January 1, 1974
Plasma calcium and the optimum dialysate calcium concentration during maintenance haemodialysisL W Fleming, W K Stewart
British Medical Journal|November 24, 1973
Letter: Muscle cramps during maintenance haemodialysisW K Stewart, L W Fleming
The Journal of Hospital Infection|August 1, 1989
The potential hazard of using multiple-dose heparin and insulin vials in continuous ambulatory peritoneal dialysisG Phillips, L W Fleming, W K Stewart
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1992
Dextran antibodies, complement conversion and circulating immune complexes after intravenous iron dextran therapy in dialysed patientsL W Fleming, W K Stewart, D Parratt
Pageof 6